Literature DB >> 65423

Characterization of suppressor cells in mice bearing syngeneic mastocytoma.

F Takei, J G Levy, D G Kilburn.   

Abstract

Suppressor cells from syngeneic P815 mastocytoma-bearing DBA/2 mice that inhibit in vitro generation of specific anti-tumor cytotoxicity were characterized. Suppressive activity was almost completely eliminated by treating suppressive spleen cells with anti-theta serum and complement. Treatment with anti-mouse lg serum and complement or with carbonyl iron did not affect their suppressive activity. When suppressive thymocytes from P815 tumor-bearing DBA/2 mice were tested for their capacity to inhibit the generation of cytotoxicity against L1210 cells, a leukemia line in DBa/2 mice, they did not affect the activity, indicating that the supressor cells in the thymocytes of P815 tumor-bearing mice are specific to the tumor. When Ficoll-Hypaque density cell separation was carried out with cytotoxic spleen cells and suppressive spleen cells from 815 tumor-bearing mice, the dense fraction was enriched for kiler cells whereas the suppressive activitty was mainly recovered in the light fraction. Therefore, killer cells and suppressor cells in P815 tumor-bearing mice are thought to be distinct populations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 65423

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.

Authors:  G M Taylor; W D Fergusson; R Harris
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

2.  Immunological memory induced by genetically transduced tumor cells.

Authors:  M M Dar; Z Abdel-Wahab; C E Vervaert; T Darrow; J Barber; H F Seigler
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

3.  Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cells.

Authors:  J K Steele; D Liu; A T Stammers; S Whitney; J G Levy
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Cancer immunotherapy.

Authors:  R E Falk
Journal:  Can Med Assoc J       Date:  1979-02-03       Impact factor: 8.262

5.  An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.

Authors:  P K Lala; I F McKenzie
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

6.  Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells.

Authors:  R J North
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762.

Authors:  J Bonaventure; V N Nigam; C A Brailovsky
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Fc-receptor-bearing cells in spleen of mice injected with cell-free Ehrlich ascites fluid (EAF).

Authors:  J Gabrilovac; K Pachmann; S Thierfelder
Journal:  Blut       Date:  1980-10

9.  Cytotoxic T lymphocytes in DBA/2 mice harboring L5178Y cells in a tumor-dormant state.

Authors:  M A Marsili; M K Robinson; G A Truitt; E F Wheelock
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor.

Authors:  T Maier; J G Levy
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.